Search the Newsreel

Cabaletta Bio (CABA): T. Rowe Price reports 11.6% common stock stake

T. Rowe Price Investment Management, Inc. has reported an 11.6% ownership stake in Cabaletta Bio (CABA) common stock, amounting to 18,869,907 shares. The firm holds sole voting power over 18,776,448 shares and sole dispositive power over all 18,869,907 shares, explicitly denying beneficial ownership despite …

What might Midtown's new Natural Grocers look like? See renderings

Natural Grocers plans to build a new 18,000-square-foot store in Midtown Fort Collins at 2839 S. College Ave., formerly occupied by a Joann fabric store and a car dealership. The development plan is currently under city review, with a potential hearing in November. Renderings …

Martin Marietta Materials, Inc. (NYSE:MLM) Raises Dividend to $0.84 Per Share

Martin Marietta Materials (NYSE:MLM) has increased its quarterly dividend by 1.2% to $0.84 per share, marking its ninth consecutive year of dividend increases. The dividend, payable on September 30th to shareholders of record on September 1st, is well-covered with a low payout ratio of …

Caballeta Bio (CABA) stake: Bain Capital Life Sciences reports 9.99% position

Bain Capital Life Sciences Opportunities III, L.P. has reported a 9.99% beneficial ownership stake in Cabaletta Bio (CABA), as detailed in a recent SCHEDULE 13G/A filing. This ownership comprises 7,709,188 common shares, a warrant for up to 7,500,000 shares, and a pre-funded warrant for …

Martin Marietta Materials raises dividend to $0.84 per share

* Martin Marietta Materials (MLM [https://seekingalpha.com/symbol/MLM]) declares $0.84/share quarterly dividend [https://seekingalpha.com/pr/20619149-martin-marietta-increases-quarterly-cash-dividend], 1.2% increase from prior dividend of $0.83. * Forward yield [https://seekingalpha.com/symbol/MLM/dividends/yield?source=news_bullet] 0.62% * Payable Sept. 30; for shareholders of record Sept. 1; ex-div Sept. 1. * See MLM Dividend Scorecard, Yield Chart, & …

Form 8K Martin Marietta Materials Inc For: 14 August By Investing.com

This article reports on the filing of a Form 8K by Martin Marietta Materials Inc. on August 14th. The brief announcement provides no specific details from the filing but notes its availability through Investing.com. It indicates that the company's stock symbol is MLM.

Martin Marietta Materials (MLM) Stock May Trade Below Fair Value Today

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Martin Marietta Materials stock sits at an interesting crossroads, with the intrinsic value estimate …

Ibotta director Thomas Lehrman sells $1.53m in company stock.

Ibotta director Thomas D. Lehrman sold approximately $1.53 million worth of company stock through multiple transactions on August 11 and 12, 2026. These sales, both direct and indirect, occurred at weighted average prices between $35.73 and $36.22 per share. The stock has seen a …

Natural Grocers (NGVC) Q3 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Vice President, Treasurer - Jessica ThiessenCo-President - Kemper IselyChief Financial Officer - Richard Hallé TAKEAWAYS Net Sales -- $334.7 million, representing a 1.8% increase driven by a $4 …

Martin Marietta Materials, Inc. Raises Quarterly Dividend, Payable on September 30, 2026

Martin Marietta Materials, Inc. announced that its Board of Directors approved an increase in its quarterly cash dividend from $0.83 to $0.84 per share. This translates to an annualized dividend of $3.36 per share. The dividend is payable on September 30, 2026, to shareholders …

Ibotta (IBTA) director Lehrman disposes of 42,407 Class A shares in August trades

Ibotta (IBTA) director Thomas D. Lehrman sold a total of 42,407 Class A Common Stock shares through six open-market transactions on August 11–12, 2026. These sales included both direct holdings and indirect sales via entities like Four Ways, LLC and LFP 2, LLC, where …

Martin Marietta Increases Quarterly Cash Dividend

Martin Marietta Materials, Inc. announced an increase in its quarterly cash dividend from $0.83 to $0.84 per share, marking its eleventh consecutive annual dividend increase. This decision reflects the company's commitment to shareholder returns and confidence in its aggregates-led business model and cash flow …

Martin Marietta Marks 11th Consecutive Annual Dividend Increase

Martin Marietta (NYSE: MLM) announced an increase in its quarterly cash dividend from $0.83 to $0.84 per share, marking its eleventh consecutive annual dividend increase. This annualized dividend of $3.36 per share is payable on September 30, 2026, to shareholders of record as of …

MLM6482398 Bond Yield and Price — FINRA:MLM6482398

This article provides details on the Martin Marietta Materials, Inc. (FINRA: MLM6482398) bond, featuring a 5.4% coupon rate and maturing on January 30, 2034. It lists key terms like face value, minimum denomination, and issuer details, along with company information. The page also promotes …

MLM6482400 Bond Yield and Price — FINRA:MLM6482400

This article provides detailed financial information for the Martin Marietta Materials, Inc. 5.625% 15-AUG-2036 bond (MLM6482400 FINRA). It includes key terms such as outstanding amount, face value, coupon rate, and maturity date, along with issuer details and identifiers. The bond overview highlights the company's …

Martin Marietta Materials (MLM) Prices Senior Notes, Is The Stock Fully Priced?

Cabaletta Bio (NASDAQ:CABA) Releases Earnings Results, Beats Estimates By $0.03 EPS

Cabaletta Bio (NASDAQ:CABA) reported a quarterly loss of $0.34 per share, exceeding analyst estimates by $0.03. Despite beating estimates, the stock fell to $2.73 during midday trading, significantly below its 52-week high of $4.23. Analysts maintain a "Moderate Buy" rating with an average price …

Cabaletta Bio stock maintains Buy rating at TD Cowen on trial progress

TD Cowen has reiterated its Buy rating on Cabaletta Bio (NASDAQ:CABA) due to the company's progress in its RESET clinical trial portfolio. The stock has shown strong performance with a 30% year-to-date gain and 67% over the past year. Cabaletta Bio's pivotal trial data …

Cabaletta Bio (CABA) Q2 Earnings Beat Expectations; Market Focuses on Growth Potential Despite Losses

Martin Marietta reports increased revenue for Q2

Martin Marietta Materials Inc. announced a 21 percent increase in revenue for the second quarter of 2026, reaching $1.95 billion, despite a 12 percent decrease in net income from continuing operations to $256 million. The company reported record aggregate shipments of 61.6 million tons, …

Cabaletta Bio reports Q2 2026 net loss of $51.0M; cash position $225.1M supports operations into mid-2027

Cabaletta Bio reported a net loss of $51.0 million for Q2 2026, with operating expenses of $52.0 million. The company's cash position of $225.1 million, as of June 30, 2026, is expected to fund operations into mid-2027. Cabaletta also highlighted progress in its RESET …

Cabaletta Bio Reports $51.0 Million Second-Quarter Net Loss

Cabaletta Bio reported a net loss of $51.0 million, or $0.34 per share, for the second quarter of 2026, with research and development expenses at $44.4 million. The company ended the quarter with $225.1 million in cash, expected to fund operations into mid-2027, and …

Cabaletta Bio, Inc. 2Q 2026: Net loss $(51.0)M, EPS $(0.34) — 10-Q Summary

Cabaletta Bio, Inc. reported a net loss of $(51.0)M for the second quarter of 2026, with a diluted loss per share of $(0.34). The company remains pre-revenue, focusing on advancing multiple RESET™ clinical programs and scaling manufacturing. They have achieved clinical progress with positive …

Cabaletta Bio (CABA) lifts cash to $225M while advancing rese-cel toward BLA

Cabaletta Bio (CABA) announced its second quarter 2026 financial results, reporting a net loss of $51.0 million but increasing its cash, cash equivalents, and short-term investments to $225.1 million, which is expected to fund operations into mid-2027. The company is advancing its lead CAR …

Form 8K Cabaletta Bio Inc For: 13 August By Investing.com

This article reports on Cabaletta Bio Inc.'s Form 8K filing for August 13th, as published by Investing.com. It is a brief announcement without further details within the provided text. The article is primarily a stub, directing readers to a comments section.

Natural Grocers by Vitamin Cottage (NYSE:NGVC) Could Be A Buy For Its Upcoming Dividend

Natural Grocers by Vitamin Cottage (NYSE:NGVC) is about to trade ex-dividend, offering a payment of US$0.15 per share, totaling US$0.60 annually, which represents a 2.2% trailing yield. The company's dividend appears sustainable, with a modest payout ratio of 28% of profits and 59% of …

ArcelorMittal remains Morgan Stanley’s preferred way to invest in European reindustrialisation

Morgan Stanley analyst Alain Gabriel reiterates ArcelorMittal as his preferred investment for European reindustrialisation due to its significant European shipment base and spare capacity. He believes that fiscal support and an assertive "Made in Europe" industrial policy will accelerate industrial reshoring, benefiting European steelmakers …

Handelsbanken Fonder AB Raises Position in Martin Marietta Materials, Inc. $MLM

Handelsbanken Fonder AB increased its stake in Martin Marietta Materials, Inc. (NYSE:MLM) by 18.3% in the second quarter, bringing its total holdings to 37,395 shares valued at $21.57 million. Other institutional investors also adjusted their positions in the construction company, which reported strong Q2 …

CABA Stock On Track For Best Day In 6 Months After Positive Early Results From Cell Therapy Trial

Martin Marietta Materials Announces $5.5 Billion Senior Notes Offering Across Five Tranches

Martin Marietta Materials, Inc. (NYSE: MLM) has announced a $5.5 billion senior notes offering across five tranches, with maturities ranging from 2029 to 2056 and interest rates from 4.850% to 6.375%. The underwriting agreement was executed with lead underwriters including Goldman Sachs & Co. …

Does Upgraded 2026 Guidance and Buybacks Change The Bull Case For Martin Marietta Materials (MLM)?

Martin Marietta Materials Inc. stock outperforms competitors despite losses on the day

Shares of Martin Marietta Materials Inc. (MLM) fell by 1.76% on Wednesday, closing at $543.90, despite the S&P 500 Index rising and the Dow Jones Industrial Average slightly falling. This decline ended a three-day winning streak for the company's stock.

Natural Grocers' Stock Down 14% as Q3 Earnings Decline Y/Y

Natural Grocers by Vitamin Cottage, Inc. (NGVC) saw its stock decline by 13.8% following a Q3 fiscal 2026 earnings report that showed a year-over-year decrease in earnings per share and net income. Despite a 1.8% rise in net sales, profitability metrics like operating income, …

Adage Capital discloses 8.43% Cabaletta Bio (CABA) stake including warrant shares

Adage Capital Management, L.P. and its related parties have disclosed an 8.43% beneficial ownership stake in Cabaletta Bio, Inc. (CABA). This stake totals 14,174,758 shares of Common Stock, which includes 5,000,000 shares exercisable from warrants held by Adage Capital Partners, L.P. The filing indicates …

ArcelorMittal (MT) vs. Microsoft Corporation (MSFT): A Steel Giant Bets Its Future on Azure

On August 3, 2026, Reuters reported that Steelmaker ArcelorMittal S.A. (NYSE:MT) is expanding its partnership with Microsoft Corporation (NASDAQ:MSFT). It is adding Microsoft Fabric, Purview, and Foundry to its Azure-based "Cloud First, Data Centric" strategy, aiming to modernize its IT systems and embed AI …

Martin Marietta prices $5.5B debt to fund Lhoist acquisition

Martin Marietta Materials Inc. (NYSE: MLM) has priced $5.5 billion in senior notes across five tranches to finance its $13.5 billion acquisition of Lhoist North America, Inc. This financing, following regulatory approval, is the final major hurdle for the deal, which is now expected …